Verve Therapeutics Ratios and Metrics

Market cap in millions GBP. Fiscal year is April - March.

Millions GBP. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '25 Aug 4, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Capitalization	1	10	31	11	-
Market Cap Growth	-92.35%	-68.00%	189.51%	-	-
Enterprise Value	0	8	30	10	-
Last Close Price	0.01	0.08	0.25	0.10	-
PS Ratio	1.02	4.47	17.91	13.72	-
PB Ratio	2.50	3.12	9.74	5.83	-
P/TBV Ratio	18.55	3.19	9.74	5.83	-
P/FCF Ratio	-	13.34	-	-	-
P/OCF Ratio	-	13.23	-	-	-
EV/Sales Ratio	0.26	3.54	17.20	13.14	-
EV/EBITDA Ratio	-	-	-	99.35	-
EV/EBIT Ratio	-	-	-	101.28	-
EV/FCF Ratio	-0.38	10.58	-	-	-
Debt / Equity Ratio	1.15	1.28	0.18	0.33	0.26
Debt / EBITDA Ratio	-	-	-	3.45	0.61
Debt / FCF Ratio	-	5.48	-	-	-
Asset Turnover	0.37	0.35	0.52	0.46	-
Quick Ratio	1.07	1.06	4.15	3.54	2.10
Current Ratio	1.07	1.06	4.19	3.64	2.10
Return on Equity (ROE)	-43.31%	-117.80%	-21.50%	-32.59%	-
Return on Assets (ROA)	-9.88%	-4.91%	-10.77%	3.75%	-
Return on Capital (ROIC)	-13.65%	-5.68%	-11.28%	4.15%	-
Return on Capital Employed (ROCE)	-	-	-	5.50%	22.70%
Earnings Yield	-234.90%	-37.46%	-1.78%	-3.52%	-
FCF Yield	-66.96%	7.50%	-2.00%	-0.38%	-
Buyback Yield / Dilution	-15.08%	-17.22%	-43.30%	-29630.53%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.